Friday, January 25, 2013

• EXELIXIS, INC. Files SEC form 8-K, Other EventsEDGAR Online (Fri, Jan 25)

Thursday, January 24, 2013

• Exelixis Announces COMETRIQ™ (cabozantinib) Is Now Available in the U.S.Business Wire (Thu, Jan 24)

Wednesday, January 23, 2013

• Biotech: Core and Exploreat Motley Fool (Wed, Jan 23)
• One Biotech Pony, Lots of Tricksat Motley Fool (Wed, Jan 23)

Friday, January 18, 2013

• Pipeline Advances at ExelixisZacks (Fri, Jan 18)

Thursday, January 17, 2013

• Do Orphan Drug Developers Belong in Your Portfolio?at Motley Fool (Thu, Jan 17)
• Biotech Industry Expected to Experience More M&A Activity in 2013Marketwired (Thu, Jan 17)

Wednesday, January 16, 2013

• EXELIXIS, INC. Files SEC form 8-K, Other EventsEDGAR Online (Wed, Jan 16)

Tuesday, January 15, 2013

• JPMorgan Healthcare Conference Highlights: Exelixisat Motley Fool (Tue, Jan 15)
• 3 Highly Shorted Stocks Under $5 Being Snapped By Hedge Fundsat Seeking Alpha (Tue, Jan 15)

Wednesday, January 9, 2013

• Exelixis' CEO Presents at J.P. Morgan 31st Annual Healthcare Conference (Transcript)at Seeking Alpha (Wed, Jan 9)

Friday, January 4, 2013

• 3 Biotech Stocks You Can Buy in 2013at Motley Fool (Fri, Jan 4)

Thursday, January 3, 2013

• Labrys Bioscience, founded by Corey Goodman, snags Pfizer migraine drug, $31 millionat bizjournals.com (Thu, Jan 3)

Wednesday, December 26, 2012

• 3 Stocks Near 52-Week Lows Worth Buyingat Motley Fool (Wed, Dec 26)

Monday, December 24, 2012

• EXEL Trading Below Director's Recent Buy Priceat Forbes (Mon, Dec 24)

Saturday, December 22, 2012

• 5 Medical Stock Losers From Last Week With High Short Ratiosat Seeking Alpha (Sat, Dec 22)

Friday, December 21, 2012

• 5 Reasons to Worry About 2013at Motley Fool (Fri, Dec 21)

Wednesday, December 19, 2012

• Shorting Alexza Pharma On FDA's Adasuve Approvalat TheStreet (Wed, Dec 19)

Monday, December 17, 2012

• Exelixis Rebounds From 'Sell The News' Reactionat Seeking Alpha (Mon, Dec 17)

Friday, December 14, 2012

• EXELIXIS, INC. Files SEC form 8-K, Temporary Suspension of Trading Under Registrant's Employee Benefit PlansEDGAR Online (Fri, Dec 14)

Thursday, December 13, 2012

• What Are Insiders Buying Recently?at Motley Fool (Thu, Dec 13)
• Exelixis Announces Webcast of January 9 Presentation at the J.P. Morgan 31st Annual Healthcare ConferenceBusiness Wire (Thu, Dec 13)

Tuesday, December 11, 2012

• Top Buys by Top Brass: EVP Schwab's $109.8K Bet on EXELat Forbes (Tue, Dec 11)

Monday, December 10, 2012

• Buy, Sell, or Hold: Navidea Biopharmaceuticalsat Motley Fool (Mon, Dec 10)
• Aveo Pharmaceuticals: A Hidden Gem Or A Hidden Disasterat Seeking Alpha (Mon, Dec 10)

Add EXEL News to My Yahoo!